SCOPE: FDA facilitates AI and ML use for clinical trials and drug development
Two FDA representatives FDA spoke at the ongoing 2024 SCOPE Summit about how the agency is focusing on AI.
Two FDA representatives FDA spoke at the ongoing 2024 SCOPE Summit about how the agency is focusing on AI.
What's Your Reaction?
